Oncimmune (ONC) Competitors

Oncimmune (LON:ONC) and Genflow Biosciences (LON:GENF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment.

Which has more risk & volatility, ONC or GENF?

Oncimmune has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, Genflow Biosciences has a beta of 2.37, meaning that its share price is 137% more volatile than the S&P 500.

Does the MarketBeat Community favor ONC or GENF?

Oncimmune received 68 more outperform votes than Genflow Biosciences when rated by MarketBeat users.

Company	Underperform	Outperform
Oncimmune	Outperform Votes 68 59.13%	Underperform Votes 47 40.87%
Genflow Biosciences	N/A	N/A

Which has preferable valuation and earnings, ONC or GENF?

Oncimmune has higher revenue and earnings than Genflow Biosciences. Genflow Biosciences is trading at a lower price-to-earnings ratio than Oncimmune, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncimmune	£1.86M	0.70	£10.79M	£8.87	0.13
Genflow Biosciences	-£226.19K	-15.40	-£1.76M	-£0.53	-1.93

Is ONC or GENF more profitable?

Genflow Biosciences has a net margin of 778.46% compared to Oncimmune's net margin of 581.63%. Genflow Biosciences' return on equity of -208.12% beat Oncimmune's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oncimmune	581.63%	-2,277.74%	-26.38%
Genflow Biosciences	778.46%	-208.12%	-58.66%

Do institutionals & insiders hold more shares of ONC or GENF?

25.0% of Oncimmune shares are owned by institutional investors. Comparatively, 9.2% of Genflow Biosciences shares are owned by institutional investors. 31.0% of Oncimmune shares are owned by company insiders. Comparatively, 64.2% of Genflow Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the media favor ONC or GENF?

In the previous week, Genflow Biosciences' average media sentiment score of 0.00 beat Oncimmune's score of -1.32 indicating that Genflow Biosciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Oncimmune	Negative
Genflow Biosciences	Neutral

Summary

Oncimmune beats Genflow Biosciences on 8 of the 13 factors compared between the two stocks.